New agreement
September 20, 2013
Solural Pharma ApS enters into a Master Service Agreement with a major US Pharmaceutical company on the development of a new oral treatment within hormone disorders.
Recent news
- New Eurasia patent December 25, 2020
- New Manufacturing Authorisation December 18, 2020
- New European patent December 9, 2020
Contact us
- Energivej 42, DK 2750 Ballerup, Copenhagen, Denmark
- info@soluralpharma.com
- Find us on map